The market size for High-Performance Liquid Chromatography is expected at around USD 3.81 Billion in 2021 and is expected to grow at a CAGR of 5.7% to reach USD 5.02 Billion by 2026.
The High-Performance Liquid Chromatography (HPLC) is a method in analytical chemistry. The HPLC is used to separate, identify and measure the quality of each component in a mixture. The HPLC is a multipurpose method used in the clinical diagnosis of diseases & disorders and the food industry for quality control. Furthermore, the HPLC can be used for analysis in pharmaceutical labs and scientific researches. Moreover, the HPLC is an expensive and sophisticated technique. The HPLC was mostly preferred over other chromatography techniques like gas chromatography because of the reliability and accuracy. In contrast, the standard liquid chromatography technique usually relies on gravity to pass the mobile phase through the column.
The global HPLC market is primarily driven by the high sensitivity and accuracy of the HPLC technique. The ability of High-performance liquid chromatography in identifying the drug and monitor diseases and the adoption of hyphenated techniques is further accelerating the growth rate of the market. Moreover, an increase in R&D investments is fueling the HPLC market. The rise in the contract research organizers and the pharmaceutical industries globally may propel the market growth. Furthermore, the rise in the economy of the countries like China and India may boost the market in the coming years.
The manufacturers are mostly concentrating on new technologies to help researchers get high-quality analysis that is a significant opportunity for the High-Performance Liquid Chromatography market growth. Moreover, the increase in demand for the HPLC technique will boost the market.
The major restrain of the HPLC industry is the high cost of HPLC systems. The lack of highly professional laborers may hinder the market growth. The supplier and the buyer's bargaining power may affect the market growth. The strict rules by the governments are another significant factor restraining the market.
The rise in the competition for new techniques will be a challenge for the HPLC market in the coming years. The lack of awareness about the HPLC techniques in some emerging countries may be a drawback for the market.
Impact of COVID-19 on the global HPLC Market:
The COVID-19 was well known as the coronavirus globally. The WHO had announced the COVID-19 as a pandemic in March 2020. More than 200 countries had announced a strict lockdown guideline to curb the spread of the novel coronavirus disease. Due to lockdown, all companies got shut and seen huge losses during the pandemic. The High-Performance Liquid Chromatography market had faced a lot of difficulties with sustaining the growth. The break of the supply chain is the major drawback for the market. The insufficient funding to research and academic institutes and a decrease in demand for the product hinder the market. But few key players in the market are trying their best to be in the market, such as Agilent Technologies, with established business continuity plans (BCPs) trying their best to secure that their production does not fall behind.
Market Size Available
2020 to 2026
2021 to 2026
By-Products, Instruments, Consumables, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This research report on the global high-performance liquid chromatography market has been segmented and sub-segmented based on the products, instruments, consumables, application, and region.
HPLC Market - By Product:
Based on the product, the HPLC Instruments segment is expected to increase during the forecast period. The rise in the use of HPLC equipment to analyze various sectors is boosting the market. The increase in pharmaceutical, biotech, food, and agriculture research and development is fueling the market. The consumable market is expected to rise at the highest CAGR during the forecast period. The growing investments in the healthcare sector are boosting the market.
HPLC Market - By Instruments:
The systems segment is holding prominent shares of the market owing to rising demand for the use of these systems in healthcare. Detectors segment to have a substantial growth rate in the coming years.
HPLC Market - By Consumables:
The HPLC Consumables segment is leading the Global HPLC Market. The consumables segment was further segmented into columns and filters. The advancement in column technology and pumps are boosting the market. The adoption of chromatographic techniques for testing the validity and specificity of the drugs is fueling the market. Moreover, the rise in the Research and Development (R&D) was pushing the market.
HPLC Market - By Application:
The clinical research segment was estimated to grow with a higher CAGR during the forecast period based on the application. It is used to know inorganic impurities such as plant or animal proteins existing in pharmaceutical bulk materials or excipients or catalysts. The increase in investments in this segment is boosting the HPLC clinical research market.
HPLC Market - By Region:
North America holds the major market share owing to the presence of major players. North America holds the major market share during the forecast period. North America registered USD 1.26 Billion in 2020; by 2025, the market was expected to record 1.62 Billion with a CAGR of 5.2% during the forecast period. The United States and Canada are the most significant contributors to the North American market. The increase in R&D investments in the US is the primary reason for the market growth. The booming pharmaceutical industry in Canada is fueling the market. The US Food and Drug Administration's recommendations on the use of chromatographic techniques to ensure proper identity, purity, and concentration of pharmaceuticals increase the use of high-performance liquid chromatography techniques. The government's policies and fundings are boosting the market growth.
The European market is predicted to account for the second-largest share in the global market during the forecast period. Europe has registered USD 1.19 Billion in 2020. By 2025, the market is expected to reach USD 1.52 Billion at a CAGR of 5.2% during the forecast period. The increased investments by major players in the pharmaceutical and biotechnology industry are propelling the market. The growing demand for the LC-MS technique and increase in R&D investments are boosting the market. Moreover, the major contributor of the European market was United Kingdom, Germany, and Russia. The rise in awareness of the HPLC techniques and government policies is fueling the market.
Asia-pacific is expected to witness a major growth rate due to numerous companies in this region. Asia-pacific is expected to witness a significant growth rate during the forecast period. The HPLC market in the Asia Pacific was around USD 790 Million in 2020. It is expected to grow at a CAGR of 7.2% to reach 1,120 Million by 2025. Increasing interest in research activities in developing countries like China, India, and Japan will boost the market expansion. The rise in awareness about the HPLC techniques are propelling the market. The easy government policies and the low maintenance cost are grabbing the investor's attention, which leads to an increase in the HPLC market in the Asia Pacific in upcoming years.
KEY MARKET PLAYERS:
Noteworthy leading the global high-performance liquid chromatography market profiled in this report are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific Inc., GE Healthcare, PerkinElmer Inc., Bio-Rad Laboratories Inc., Gilson Inc., Phenomenex Inc., and JASCO Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
220.127.116.11 Fraction Collectors
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Clinical research
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Application
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Waters Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Agilent Technologies
8.3 Shimadzu Corporation
8.4 Thermo Fisher Scientific Inc
8.5 GE Healthcare
8.6 PerkinElmer Inc.
8.7 Bio-Rad Laboratories Inc
8.8 Gilson Inc.
8.9 Phenomenex Inc.
8.10 JASCO Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures